How can the ATMP facilities at KI and Karolinska support your product development?

Developing Advanced Therapy Medicinal Products (ATMPs) is a growing field. Karolinska Institute and Karolinska University Hospital have unique facilities and expertise in this field.

We welcome you to this breakfast seminar to learn more about how your company can access these facilities and benefit from the services, resources and competence. Ask your questions to researchers and entrepreneurs from the facilities and growing ATMP community during the closing Q&A session.

Register here. 

When?

2022-04-26 08:00 – 10:00

Where?

Innomedicum, Nanna Svartz Väg 2 at Campus Solna. Room: Daggkåpa

Organizers

Stockholm Life Tech (Region Stockholm, Akademiska Hus, Flemingsberg Science, Karolinska Institutet, Karolinska Institutet Science Park, Karolinska University Hospital, Stockholm Science City)

Program

8:00 Breakfast & Networking

8:30 Welcome!

8:40 Kristina Kannisto, Project leader Centre for Advanced Medical Products (CAMP), Swelife ATMP and ATMP Sweden, will start with an overview of the ATMP landscape in Sweden and the environment in Stockholm. Kristina is also the single Entry Point och regulatory support at Karolinska Centrum för Cellterapi (KCC).

8:50 Anna Pasetto, Facility Manager at the pre-GMP facility at ANA Futura, tells about their offer to companies followed by Magnus Essand, Professor of gene therapy at Uppsala University, CSO and co-founder of Elicera Therapeutics will share their experience from working with ANA Futura.

9:10 Pontus Blomberg, Head of Unit for KCC and GMP production unit Vecura, tells about their offer to companies followed by Johan Liwing, CEO at XNK Therapeutics who shares his experience from the GMP facility at Vecura.

9:30 Panel: All speakers are invited to a panel to answer questions from the audience

Welcome to stay after the meeting for a tour of A Working Lab @ Innomedicum to hear more about this innovation hub at Campus Solna.

Register not later than April 21th. A limited number of places are available. The seminar will not be streamed.

Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

BIO-Europe – A Conference for Future Medical Innovations

BIO-Europe is Europe’s largest partnering conference for the biotechnology, pharmaceutical, and life science industries. The conference serves as a meeting place where companies, researchers, investors, and other stakeholders in the industry can network, establish collaborations, and discuss business opportunities. The event is held annually in various European cities. This year, BIO-Europe took place in Stockholm from November 4th to 6th, where discussions included advanced cell and gene therapies as the medicine of the future.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

Vill du veta mer?
Prenumerera på vårt nyhetsbrev.

CF_logo_neg
2022-03-31T08:54:00+02:00
Go to Top